CIK 0000890821 · Non-accelerated filer<br>Smaller reporting company
Enveric Biosciences, Inc.
Sign in to watch- Ticker
- ENVB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 954484725
- Phone
- (617) 444-8400
- Business address
- 245 FIRST STREET RIVERVIEW II 18TH FLOOR, CAMBRIDGE, MA, 02142
- Former names
- AMERI Holdings, Inc., SPATIALIZER AUDIO LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-01-01 | Pearse Robert G. Director | Option exercise | +9,063 | 31,763 | ||
| 2018-01-01 | Pearse Robert G. Director | Option exercise · Restricted Stock Unit | −9,063 | 0 | ||
| 2018-01-01 | Langer Arthur M Director | Option exercise | +7,680 | 77,542 | ||
| 2018-01-01 | Langer Arthur M Director | Option exercise · Restricted Stock Unit | −7,680 | 0 | ||
| 2018-01-01 | Eberwein Jeffrey E. Director | Option exercise | +9,985 | 37,051 | ||
| 2018-01-01 | Eberwein Jeffrey E. Director | Option exercise · Restricted Stock Unit | −9,985 | 0 | ||
| 2018-01-01 | Balakrishnan Venkatraman Director | Option exercise | +9,524 | 12,519 | ||
| 2018-01-01 | Balakrishnan Venkatraman Director | Option exercise · Restricted Stock Unit | −9,524 | 0 | ||
| 2018-01-01 | Angelis Dimitrios Director | Option exercise | +8,602 | 32,206 | ||
| 2018-01-01 | Angelis Dimitrios Director | Option exercise · Restricted Stock Unit | −8,602 | 0 | ||
| 2017-12-29 | Eberwein Jeffrey E. Director | Other acquisition | +21,410 | $50.00 | $1.1M | 405,395 |
| 2017-12-26 | Kelton Brent Chief Executive Officer | Grant or award · Option (Right to Buy) | +100,000 | 100,000 | ||
| 2017-12-21 | Rai Dhruwa N Director | Option exercise | +333,333 | 982,112 | ||
| 2017-12-21 | Rai Dhruwa N Director | Option exercise · Restricted Stock Unit | −333,333 | 0 | ||
| 2017-11-17 | Devanur Giri President & CEO | Purchase | +12,121 | $4.12 | $50K | 2,191,346 |
| 2017-11-17 | Devanur Giri President & CEO | Purchase · Warrant (Right to Buy) | +12,121 | $0.01 | $121 | 12,121 |
| 2017-11-17 | Eberwein Jeffrey E. Director | Purchase | +100,000 | $4.12 | $412K | 2,972,592 |
| 2017-11-17 | Eberwein Jeffrey E. Director | Purchase · Warrant (Right to Buy) | +100,000 | $0.01 | $1K | 100,000 |
| 2017-11-17 | Rai Dhruwa N Director | Purchase | +145,450 | $4.12 | $599K | 648,779 |
| 2017-11-17 | Rai Dhruwa N Director | Purchase · Warrant (Right to Buy) | +145,450 | $0.01 | $1K | 145,450 |
Page 8 of 20 · 386 trades